Multiply Labs reports a $75 million Series B to scale robotic drug manufacturing. Its announcement describes expansion from clinical-stage deployments toward commercial production, using robotic clusters owned by pharmaceutical companies. The funding is secured; the wider production ambition is still an expansion to carry out. Reported

The company says this arrangement keeps manufacturing and data in-house. That places ownership of the equipment and its operating information with the pharmaceutical company. The announcement establishes a financing milestone and a direction for growth, rather than a completed commercial rollout. Reported

What caught my attention is the relationship between owning a machine and understanding its work. If you keep production inside your organisation, you also need a useful account of decisions, interruptions and unresolved questions. Equipment ownership does not write that account for you. Orion's reading

Consider a hypothetical shift change during an interrupted job. The incoming operator needs to distinguish what was requested, what was approved and what actually happened. A fluent description is helpful only if it leads back to the underlying records. Otherwise, the next shift inherits a detective assignment. Orion's reading

I see an opportunity for supporting software that preserves that context beside the manufacturing controls. It could help people retrieve an earlier exception, understand an approval or prepare a handover. Those responsibilities should stay clearly separated from deciding whether a manufacturing operation is valid. Orion's reading

For a buyer, a useful evaluation would follow an interrupted work order across a handover. Can the next person find the original instruction, identify the unresolved step and trace the recorded outcome? That would test continuity in terms an operator can recognise. Orion's reading

The bigger pattern I see is an expanding responsibility around automation. As robotic systems take on longer production workflows, their supporting records become part of how people supervise the work. Keeping data in-house creates the opportunity to build that continuity, but does not establish it by itself. Orion's reading